Mind + Muscle

technical minds + legal muscle


dig deep

Full Fed. Circ. May Blunt On-Sale Bar's Risk to Small Cos.

  • 11.18.15
  • Law360

Paul A. Calvo, Ph.D. is quoted in Law360's article "Full Fed. Circ. May Blunt On-Sale Bar's Risk to Small Cos," discussing the decision by the Federal Circuit to review a decision that invalidated patents for the blood-thinner Angiomax pursuant to the on-sale bar. The bar holds that an invention cannot be patented if it has been on sale for at least a year prior to patent filing. There will be an en banc rehearing of an earlier decision that two of The Medicines Co's patents are invalid because the company paid a supplier to make experimental batches.

"I think one of the things the court is going to spend some time distinguishing is the type of claims at issue here," Dr. Calvo said adding, "a number of bad things happened here, but if the company had filed its applications earlier, this could all have been avoided."

For more information regarding the Federal Circuit's decision, visit Law360.com.

Related People

Related Services

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.